View in EDS

Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.

Saved in:
Bibliographic Details
Title: Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.
Authors: Nyombayire J; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Ingabire R; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Mazzei A; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Sharkey T; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Umuhoza C; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Mukamuyango J; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Allen S; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Tichacek A; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Parker R; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Wall KM; Department of Epidemiology, Rollins School of Public Health, Laney Graduate School, Emory University, Atlanta, GA, USA. kmwall@emory.edu., Katwere M; Johnson & Johnson, Leiden, the Netherlands., Keshinro B; Johnson & Johnson, Leiden, the Netherlands., Gaddah A; Johnson & Johnson, Beerse, Belgium., Wang Y; IQVIA Research & Development Solutions, Durham, NC, USA., Forcheh CA; Johnson & Johnson, Toronto, Ontario, Canada., McLean C; Johnson & Johnson, Leiden, the Netherlands., Oriol-Mathieu V; Johnson & Johnson, Leiden, the Netherlands., Luhn K; Johnson & Johnson, Leiden, the Netherlands., Robinson C; Johnson & Johnson, Leiden, the Netherlands., Karita E; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.
Source: Nature medicine [Nat Med] 2025 Nov; Vol. 31 (11), pp. 3899-3906. Date of Electronic Publication: 2025 Sep 08.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40921806
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nyombayire+J%22">Nyombayire J</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Ingabire+R%22">Ingabire R</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Mazzei+A%22">Mazzei A</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Sharkey+T%22">Sharkey T</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Umuhoza+C%22">Umuhoza C</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Mukamuyango+J%22">Mukamuyango J</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Allen+S%22">Allen S</searchLink>; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Tichacek+A%22">Tichacek A</searchLink>; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Parker+R%22">Parker R</searchLink>; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Wall+KM%22">Wall KM</searchLink>; Department of Epidemiology, Rollins School of Public Health, Laney Graduate School, Emory University, Atlanta, GA, USA. kmwall@emory.edu.<br /><searchLink fieldCode="AU" term="%22Katwere+M%22">Katwere M</searchLink>; Johnson & Johnson, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Keshinro+B%22">Keshinro B</searchLink>; Johnson & Johnson, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gaddah+A%22">Gaddah A</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; IQVIA Research & Development Solutions, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Forcheh+CA%22">Forcheh CA</searchLink>; Johnson & Johnson, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22McLean+C%22">McLean C</searchLink>; Johnson & Johnson, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Oriol-Mathieu+V%22">Oriol-Mathieu V</searchLink>; Johnson & Johnson, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Luhn+K%22">Luhn K</searchLink>; Johnson & Johnson, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Robinson+C%22">Robinson C</searchLink>; Johnson & Johnson, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Karita+E%22">Karita E</searchLink>; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2025 Nov; Vol. 31 (11), pp. 3899-3906. <i>Date of Electronic Publication: </i>2025 Sep 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40921806
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-025-03932-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3899
    Titles:
      – TitleFull: Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nyombayire J
      – PersonEntity:
          Name:
            NameFull: Ingabire R
      – PersonEntity:
          Name:
            NameFull: Mazzei A
      – PersonEntity:
          Name:
            NameFull: Sharkey T
      – PersonEntity:
          Name:
            NameFull: Umuhoza C
      – PersonEntity:
          Name:
            NameFull: Mukamuyango J
      – PersonEntity:
          Name:
            NameFull: Allen S
      – PersonEntity:
          Name:
            NameFull: Tichacek A
      – PersonEntity:
          Name:
            NameFull: Parker R
      – PersonEntity:
          Name:
            NameFull: Wall KM
      – PersonEntity:
          Name:
            NameFull: Katwere M
      – PersonEntity:
          Name:
            NameFull: Keshinro B
      – PersonEntity:
          Name:
            NameFull: Gaddah A
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Forcheh CA
      – PersonEntity:
          Name:
            NameFull: McLean C
      – PersonEntity:
          Name:
            NameFull: Oriol-Mathieu V
      – PersonEntity:
          Name:
            NameFull: Luhn K
      – PersonEntity:
          Name:
            NameFull: Robinson C
      – PersonEntity:
          Name:
            NameFull: Karita E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1